期刊文献+

人肝癌细胞系7402、7721及癌旁肝细胞7701在重组腺病毒-胸苷激酶/更昔洛韦系统作用前后差异蛋白检测及CK18表达 被引量:1

DETECTION OF DIFFERENCE PROTEIN AND OBSERVATION OF PATHOMORPHISM ON HUMAN HEPATOMACARCINOMA CELL LINE 7402,7721 AND ADJACENT LIVER CELL 7701 BEFORE AND AFTER ADV-TK/GCV TREATMENT
下载PDF
导出
摘要 目的检测重组腺病毒-胸苷激酶/更昔洛韦(adenovirus-thymidine kinase/gancyclovir,ADV-TK/GCV)系统作用前后人肝癌细胞株7402、7721及癌旁肝细胞7701差异蛋白表达,进一步阐明ADV-TK/GCV自杀基因系统作用机制。方法利用肽质量指纹图谱和双向电泳分析法检测ADV-TK/GCV系统对人肝癌细胞7402、7721及癌旁肝细胞7701作用前后的差异蛋白;常规病理学技术苏木精伊红染色、电子显微镜技术观察作用前后细胞病理形态学改变;免疫细胞化学方法检测细胞角蛋白18(cytokeratin 18,CK18)的表达部位、分布范围及量的变化。结果7721及7701对ADV-TK/GCV系统作用不敏感,人肝癌细胞7402经自杀基因药物作用后,多种蛋白表达呈现出差异性,差异点主要表现为与物质能量代谢相关的酶类及与细胞骨架相关的蛋白,7402细胞的CK18表达上调明显。加药组7402细胞死亡明显,残留细胞体积变大,胞浆疏松,空泡变性。电镜观察显示加药组细胞器水肿,变化明显,微丝增多,且多分布于核周围,凋亡现象明显。7402免疫细胞化学染色显示加药组CK18的表达增强且向核周聚集。结论 ADV-TK/GCV自杀基因系统作用后,敏感株7402蛋白表达具有差异性,其中CK18表达显著上调且出现分布改变,并引起细胞形态学的变化。 Objective To detecte the expression of the difference proteins of the human hepatoma carcinoma cell line 7402,7721 and adjacent liver cell 7701 before and after the treatment of the adenovirus-thymidine kinase/gancyclovir ( ADV-TK/GCV ) system, further elucidating the mechanism of the suicide gene system ADV-TK/GCV on hepatoma cells. Methods Peptide mass fingerprinting (PMF) and two-dimensional electrophoresis analysis were used to test the expression of the difference proteins of the human hepatoma cell lines 7402,7721 and the adjacent liver cell line 7701 before and after the treatment of the ADV-TK/GCV system; moreover,we observed the cell pathological morphology changes after the treatment with Hematein Eosin ( HE), one of the routine methods of pathology. We also used the electron-microscopy to detect the expression port, distribution and quantity of cytokeratin 18 (CK18) of dosing group and control group with immunohistochemistry. Results 7721 and 7701 were sensitive to ADV-TK/GCV system. The expression of many proteins of the human hepatoma cell lines 7402,exhibited differences after the disposal method of suicide gene drugs,the expression of CK18 was upregulated obviously by comparative analysis. Cellular morphology changed significantly by HE. Cells in the control group were mostly spindle-shaped and nucleoli were obvious, while most cells in dosing group died. The volume of residual cell was small, round, and hyperchromatic. Electron microscopy observations showed that the control abundant organelles, accidentally saw cell apoptosis. Dosing group of cell organelle were oedematous obviously, microfilament increased and throughout around the nucleus, apoptosis phenomenon was obvious. The immunocytochemistry showed that the expression of CK18 of the control group was equally distributed in the cytoplasm and cell membrane, but the expression of CK18 of the treatment group increased and was uneven distribution, mainly concentrated in the membrane surrounding the cytoplasm, some of which were circular distribution. Conclusion After the suicide gene system ADV-TK/GCV played a role, protein expression of the sensitive line 7402 showed differences, which suggested the expression of CK18 upregulated memorably, the distribution presented differences and caused changes in the morphology.
出处 《河北医科大学学报》 CAS 2014年第5期546-550,F0002,共6页 Journal of Hebei Medical University
基金 国家科技部传染病防治重大专项(2008ZX10002-026)
关键词 肝肿瘤 差异蛋白 角蛋白质类 liver neoplasms differentially expressed proteins keratins
  • 相关文献

参考文献12

  • 1杨成芳,徐庆.肝癌生物治疗的研究进展[J].医学综述,2012,18(4):524-527. 被引量:6
  • 2SHAO D, ZENG Q, FAN Z, et al. Monitoring HSV-TK/ganciclovir cancer suicide gene therapy using CdTe/CdS core/shell quantum dots [ J ]. Biomaterials ,2012,33 ( 17 ) :4336 - 4344.
  • 3WANG Y, CANINE BF, HATEFI A. HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector [ J ]. Nanomedicine ,2011,7 (2) : 193 - 200.
  • 4盛恒炜,屠伟峰,霍枫.肝细胞癌亚细胞器蛋白质组学初步探讨[J].肝胆胰外科杂志,2013,25(3):215-218. 被引量:3
  • 5李曼,贾媛,员美娜,刘志鹏,刘殿武.真核肽链释放因子eRF3b在人肝组织及体外肝细胞中的表达[J].河北医科大学学报,2012,33(9):1091-1092. 被引量:2
  • 6AGUILAR-MELERO P,PRIETO-ALAMO M J, JURADO J, et al. Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1 [ J ]. J Proteomics ,2013,79:161 - 171.
  • 7雷霆,孙青丽,张健,韩水平,赵文宝.肝细胞肝癌患者的血清蛋白质组学研究[J].西安交通大学学报(医学版),2012,33(1):14-18. 被引量:6
  • 8DUARTE S, CARLE G, FANECA H, et al. Suicide gene therapy in cancer:where do we stand now? [ J]. Cancer Lett,2012,324 (28) :160 - 170.
  • 9CHEN L, GUO G, LIU T, et al. Radiochemotherapy of hepatocarcinoma via lentivirus-mediated transfer of human sodium iodide symporter gene and herpes simplex virus thymidine kinase gene[ J]. Nucl Med Biol,2011,38(5) :757 -763.
  • 10NANDA KD, RANGANATHAN K, DEVI U, et al. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study[ J]. Oral Surg 0ral Med Oral Pathol Oral Radiol,2012,113(2) :245 -253.

二级参考文献24

  • 1Louis L,Tamara S,David C,潘敏鸿(摘译),饶秋(摘译),周晓军(审校).GPC3在鉴别小肝癌与肝硬化、异型增生结节和局灶性结节性增生中的作用[J].临床与实验病理学杂志,2006,22(6):653-653. 被引量:44
  • 2ZHOURAVLEVA G, FROLOVA L, LE GOFF X,et aL Termination of translation in eukaryotes in governed by two interacting polypeptide chain release factors, eRF1 and eRF3 [ J]. EMBO J, 1995,14(16) :4065 -4072.
  • 3OZAWA K,MURAKAMI Y, EKI T, et al. Mapping of the human GSPT1 gene, a human homolog of the yeast GST1 gene, to chromosomal band 16p13. 1 [ J ]. Somat Cell Mol Genet, 1992,18 (2) :189 -194.
  • 4JAKOBSEN CG, SEGAARD TM, JEAN - JEMN D, et al. Identification of eRF3b, a human polypeptide chain release factor with eRF3 activity in vitro and in vivo [ J ]. Molecular Biology, 2001,35(4) :575 -583.
  • 5Tannapfel A, Anhllt K, Hausermann P, et al. Identification ofnovel proteins associated with hepatocellular carcinomas us-ing protein microarrays [J]. J Pathol, 2003,201(2): 238-249.
  • 6Park KS, Kim H, Kim NG, et al. Proteomic analysis andmolecular characterization of tissue ferritin light chain inhepatocellular carcinoma [J]. Hepatology, 2002, 35(6): 1459-1466.
  • 7Minagawa H, Honda M, Miyazaki K, et al. Comparativeproteomic and transcriptomic profiling of the human hepa-tocellular carcinoma [J]. Biochem Biophys Res Commun, 2008,366(1): 186-192.
  • 8Chignard N, Shang S, Wang H,et al. Cleavage of endoplasmicreticulum proteins in hepatocellular carcinoma: Detection ofgenerated fragments in patient sera [J]. Gastrenterology, 2006,130(7): 2010-2022.
  • 9Song YP, Hao YW, Sun AH, et al. Sample preparation projectfor the subcellular proteome of mouse liver [J]. Proteomics,2006, 6(19): 5269-5277.
  • 10Feng JT, Shang S, Beretta L, et al. Proteomics for the earlydetection and treatment of hepatocellular carcinoma [J].Oncogene, 2006, 25(27): 3810-3817.

共引文献12

同被引文献13

  • 1Fuentes RG, Toum e K, Arai MA, et al. Scopadulciol, isolated from scoparia dulcis, induces β-catenin degradation and overcomes tumor necrosis factor-related apoptosis ligand resistance in ags human gastric adenocarcinoma cells[J].J Nat Prod,2015,78(4) :864-872.
  • 2Liu Q, Yang QM, Hu HJ, et al. Bioactive diterpenoids and flavonoids from the aerial parts of Scoparia dulcis[J].J Nat Prod, 2014,77(7) : 1594- 1600.
  • 3Stedt H, Samaranayake H, Kurkipuro J, et al. Tomato thymidine kinase-based suicide gene therapy for malignant glioma-an alternative for Herpes Simplex virus-1 thymidine kinase[J].Cancer Gene Ther, 2015,22(3) : 130- 137.
  • 4Chen C, Fang H, Han Z, et al. Novel permissive murine immunocompetent orthotopie colon carcinoma model for comparison of the antitumoral and safety profiles of three Adv-TKs[J].Gene Ther, 2014,21 (11 ) : 975 - 983.
  • 5H igashi K, Hazama S, Araki A, et al. A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model[J].Int J Oncol, 2014,45 (4): 1412-1420.
  • 6Kim YH, Moon JY, Kim EO, et al. Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up- regulated factor ( PAUF )-specific RNA replacement in pancreatic cancer mouse mode[J]. Cancer Lett, 2014,344 ( 2 ) : 223-231.
  • 7Shao D, Li J, Pan Y, et al. Noninvasive theranostic imaging of HSV-TK/GCV suicide gene therapy in liver cancer by folate- targeted quantum dot-based liposomes [J]. Biomater Sci, 2015,3(6) :833-841.
  • 8Hashimoto H, Kitano S, Yamagata S, et al. Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation [J]. Cytotherapy, 2015, 17 ( 12 ) : 1820- 1830.
  • 9Woo I-IN, Lee WI, Kim JH, et al. Combined antitumor gene therapy with herpes simplex virus-thymidine kinase and short hairpin RNA specific for mammalian target of rapamycin[J]. Int J Oncol,2015,47(6) :2233-2239.
  • 10Hayashi K, Lee JB, Maitani Y, et al. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy[J].J Gene Med, 2006,8(8) :1056-1067.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部